Feature | Coronavirus (COVID-19) | January 19, 2022 | By Avielle Siegel, Paul J. Chang, David M. Paushter, et al.

ITN's new feature, Clinical Case of the Month, features images and clinical case studies from your medical imaging colleagues

A 26-year-old man with history of diabetes and hypertension presented with 7 days of fever, chills, nausea, intractable vomiting, diarrhea and generalized weakness, but no specific upper or lower respiratory symptoms aside from mild shortness of breath.

A 26-year-old man with history of diabetes and hypertension presented with 7 days of fever, chills, nausea, intractable vomiting, diarrhea and generalized weakness, but no specific upper or lower respiratory symptoms aside from mild shortness of breath.


A 26-year-old man with history of diabetes and hypertension presented with 7 days of fever, chills, nausea, intractable vomiting, diarrhea and generalized weakness, but no specific upper or lower respiratory symptoms aside from mild shortness of breath. The patient was diaphoretic and retching on arrival. Physical examination showed diffuse abdominal tenderness, mild tachypnea and tachycardia.

Imaging Findings

A computed tomography (CT) scan of the abdomen and pelvis revealed imaging findings in the lung bases of peripheral nodular airspace and ground-glass opacities. Abdominal imaging findings showed hepatosplenomegaly and severe hepatic steatosis; no abnormalities in the gastrointestinal tract, mesentery or vasculature; and no lymphadenopathy or ascites. 

Diagnosis: Coronavirus Disease (COVID-19)

Subsequent CT chest and SARS-CoV-2 PCR testing confirmed the diagnosis of COVID-19. The patient was admitted to the hospital with a primary diagnosis of diabetic ketoacidosis, the likely cause of his abdominal pain, secondary to SARS-CoV-2 infection. The patient was discharged home 9 days later. 

Further Reading

Information for this case study was provided by the American Roentgen Ray Society (ARRS). Learn more by reading the open-access AJR article “Lung Base Findings of Coronavirus Disease (COVID-19) on Abdominal CT in Patients With Predominant Gastrointestinal Symptoms,” as well as “Unexpected Findings of Coronavirus Disease (COVID-19) at the Lung Bases on Abdominopelvic CT.” 

Call for Entries

Do you have a clinical case you’d like to share with ITN's audience? If so, please send high-resolution images and a brief written case study to [email protected]

Related COVID-19 imaging


Related Content

News | Radiology Business

Nov. 13, 2025 — Covera Health recently announced that Advanced Radiology Services (ARS) has joined its national Quality ...

Time November 17, 2025
arrow
News | Interventional Radiology

Nov. 12, 2025 — On Nov. 11, Huntsman Cancer Institute at the University of Utah (the U) opened its first specialized ...

Time November 13, 2025
arrow
News | Radiology Business

Nov. 12, 2025 — Siemens has announced plans to deconsolidate its remaining stake in Siemens Healthineers (currently ...

Time November 13, 2025
arrow
News | Orthopedic Imaging

Nov.10, 2025 — Medical imaging technology company Adaptix Ltd. has received 510(k) clearance from the U.S. Food and Drug ...

Time November 11, 2025
arrow
News | Magnetic Resonance Imaging (MRI)

Nov. 10, 2025 — There has been substantial progress in the past few years in the field of MRI in general and remote MR ...

Time November 11, 2025
arrow
News | Contrast Media

Nov. 10, 2025 — Scientists at the University of Birmingham have developed a new class of MRI contrast agents – improving ...

Time November 10, 2025
arrow
Feature | Teleradiology | Kyle Hardner

Once viewed as a solution for after-hours coverage, teleradiology is rapidly expanding into a critical part of radiology ...

Time November 06, 2025
arrow
News | X-Ray

Oct. 30, 2025 – In collaboration with OBIO, University Health Network (UHN), Canada’s leading hospital and the No. 1 ...

Time November 03, 2025
arrow
News | Magnetic Resonance Imaging (MRI) | Children's Hospital Los Angeles

Oct. 28, 2025 — Bronchopulmonary dysplasia (BPD) is the most common — and most serious — complication of extreme ...

Time October 31, 2025
arrow
News | FDA

Oct. 30, 2025 — Sirona Medical has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Sirona ...

Time October 30, 2025
arrow
Subscribe Now